(NYSE: PJC) is pleased to announce the hiring of Josh Schimmer, MD as a managing director and senior research analyst based in the firm’s New York office. Schimmer will be focused on small- and mid-cap biotechnology companies with specific emphasis in core therapeutic areas, commercialization and strategic partnerships.
Schimmer brings more than 10 years of experience to Piper Jaffray. He joined the firm from Lazard Capital Markets, and was previously at Cowen & Co., Leerink Swann, Deutsche Banc and Davidson Kempner. Schimmer holds a doctorate of medicine from the University of Toronto and a Master of Business Administration degree from Harvard Business School.
"Piper Jaffray has a strong team of healthcare professionals and we are excited to be adding another research specialist in biotechnology with Josh's hire," commented
, co-director of equity research for Piper Jaffray. "With increased emphasis on core growth areas of biotech, we see opportunities to serve the needs of our clients and build upon our market-leading healthcare platform."
Piper Jaffray has a total of
30 senior research analysts
located in Minneapolis, New York, San Francisco and Chicago. The firm provides coverage on approximately
in the following key sectors: business & financial services; clean technology & industrial growth; consumer; healthcare; and technology, media & telecommunications.
About Piper Jaffray
Piper Jaffray is a leading investment bank and asset management firm serving clients in the U.S. and internationally. Proven advisory teams combine deep industry, product and sector expertise with ready access to capital. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the United States and in London and Zurich.
Since 1895. Member NYSE and SIPC.© 2013 Piper Jaffray & Co.